谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Overall survival results from a phase III trial of trifluridine/tipiracil (FTD/TPI) vs placebo in patients (Pts) with metastatic gastric cancer refractory to standard therapies (TAGS).

K Shitara,J Tabernero,M Dvorkin,W Mansoor,H-T Arkenau,A Prokharau,M Alsina, M Ghidini,C Faustino,V Gorbunova,E Zhavrid,K Nishikawa,A Hosokawa,D Ganea,Ş Yalçın,K Fujitani, G Beretta,R Winkler,T Doi,D H Ilson

ANNALS OF ONCOLOGY（2018）

引用 1|浏览42
暂无评分
关键词
Metastatic Gastric Cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要